Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs
Abstract This study evaluated the tolerability and efficacy of the topical rho-kinase inhibitor netarsudil for canine primary corneal endothelial degeneration (PCED). Twenty-six eyes of 21 client-owned dogs with PCED were enrolled in a prospective, randomized, vehicle control clinical trial and rece...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2024-03-01
|
| Серии: | Scientific Reports |
| Online-ссылка: | https://doi.org/10.1038/s41598-024-56084-4 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|